Insider Transactions Reported by 26 Insiders of BIOMARIN PHARMACEUTICAL INC

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	3	-11,732	100%	$69.00	-$809,527
Net	-3	-11,732	-100%		-$809,527

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
JEAN JACQUES BIENAIME	Director	$55,578,092			20 May 2024
HENRY J. FUCHS	President, Worldwide R&D	$15,712,783			13 Sep 2024
Alexander Hardy	Chief Executive Officer, Director	$8,771,121			01 Dec 2025
RICHARD A. MEIER	Director	$8,025,289			20 May 2025
ELAINE HERON	Director	$7,466,785			03 Jun 2024
Brian Mueller	EVP, Chief Financial Officer	$6,928,793			14 Mar 2025
George Eric Davis	EVP, Chief Legal Officer	$5,757,618			14 Mar 2025
Charles Greg Guyer	EVP, Chief Technical Officer	$5,613,391	-$501,355	-8.2%	14 Mar 2025
Jeffrey Robert Ajer	EVP, Chief Commercial Officer	$5,535,652			02 May 2024
E. PYOTT DAVID	Director	$3,833,238			21 May 2024
V. BRYAN LAWLIS	Director	$3,194,033			23 May 2023
ROBERT J. HOMBACH	Director	$2,636,972			20 May 2025
Dennis Slamon	Director	$2,623,169			18 Mar 2024
Willard Dere	Director	$2,453,071			20 May 2025
Gregory R. Friberg	EVP, Chief R&D Officer	$2,356,284			30 Sep 2025
ELIZABETH M. ANDERSON	Director	$2,169,661			20 May 2025
Cristin Hubbard	EVP, Chief Commercial Officer	$1,830,561	-$17,723	-0.96%	20 May 2025
Maykin Ho	Director	$1,764,069			20 May 2025
Andrea Acosta	GVP, Chief Accounting Officer	$1,746,598			30 Apr 2021
Mark J. Alles	Director	$1,454,856			23 May 2023
Barbara W. Bodem	Director	$853,693			20 May 2025
Mark Enyedy	Director	$853,379			20 May 2025
Athena Countouriotis	Director	$853,379			20 May 2025
Erin Burkhart	GVP, Chief Accounting Officer	$840,600	-$290,449	-26%	19 May 2025
Timothy P. Walbert	Director	$642,143			20 May 2025
IAN T. CLARK	Director	$401,870			01 Aug 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.